Barrett's Esophagus Clinical Trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 349 clinical trials
4march upen 194

Based on the Stage 1 analysis performed in November 2014, Arm 1 was chosen for expansion in Stage 2. Stage 2 dose will be 1-5x10xE8 transduced CART-19 cells. The dose of 1-5 x 10xE8 T-cells in Stage 2 will be administered via split dosing: 10% on Day 1 (1-5x10xE7), 30% …

  • 0 views
  • 19 Feb, 2024
2D AND 4D CONTRAST-ENHANCED ULTRASOUND EVALUATION OF HEPATOCELLULAR CARCINOMA CHEMOEMBOLIZATION

This is an open-label, non-randomized trial that will be conducted at three clinical sites. The subject population will be patients undergoing transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma (HCC) at Thomas Jefferson University, The University of California, San Diego, and University of Pennsylvania.

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Randomized Controled Trial of Transcutaneous Magnetic Stimulation of the Stellate Ganglion to Treat Ventricular Tachycardia Storm

Arrhythmia burden will be monitored after a single session of stimulation.

  • 0 views
  • 19 Feb, 2024
  • 1 location
The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer Patients

The purpose of the current study is to assess the effectiveness of a behavioral treatment for insomnia (also known as Cognitive Behavioral Therapy for Insomnia) on both insomnia and cancer-related pre and post Radiation Therapy. Information from the primary study will be used in conjunction with the data from this …

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Pilot Proof of Concept Single-Center Study of the Use of Oritavancin in Systemic Staphylococcus aureus Infections in Patients with Opioid Use Disorder

The study participants will be in the study for approximately 2 months including the screening, intervention phase and the 6 weeks of follow-up time

  • 0 views
  • 19 Feb, 2024
  • 1 location
Clinical Outcomes Assessment of the MitraClip Percutaneous Therapy for High Surgical Risk Patients

This is a study of the MitraClip, percutaneous mitral valve repair system in patients with moderate to severe to severe functional mitral regurgitation who need surgical repair but are deemed not appropriate for surgery. Patients will be randomized in a 1:1 fashion to treatment with the Mitra Clip system or …

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Randomized Double-blind Placebo-controlled Clinical Study to Evaluate Mavacamten (MYK-461) in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

This is a Phase 3, double-blind, randomized, placebo-controlled, multicenter, international, parallel-group study to evaluate the safety, tolerability, and efficacy of mavacamten compared with placebo (1:1) in participants with symptomatic oHCM. Approximately 220 participants will be enrolled. This includes ~80 participants (~40 per treatment group) who consent to participate in a …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Defining the role of germline genetic variants in gastric cancer tumorigenesis

Both people with increased risk as well as people with average risk of gastric cancer will be asked to participate in this study. If you agree to join the study, at the time of an upper endoscopy that is being performed as part of your routine care, you will have …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Effect of Organic Nitrates and Hydralazine on Wave Reflections and Left Ventricular Structure and Function in Heart Failure with Preserved Ejection Fraction

This is a double-blind, placebo-controlled pilot randomized study in which the effects of placebo and 2 vasoactive interventions (isosorbide dinitrate or isosorbide dinitrate + hydralazine) administered for 24 weeks will be assessed in patients with HFPEF. A total of 42 patients with HFPEF will be enrolled across all sites over …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Preliminary Evaluation of Septin9 in Familial Adenomatous Polyposis Patients

FAP patients and their family controls participating in the study are followed up clinically and with blood draws at least every 6 months for duration of 2 years. These follow-up might be more frequent, if warranted by the clinical course of the disease in the participating patients. Blood draws in …

  • 0 views
  • 19 Feb, 2024
  • 1 location